User profiles for Henning Schröder

Henning Schröder

Leuphana University Lueneburg
Verified email at leuphana.de
Cited by 781

NO-independent regulatory site on soluble guanylate cyclase

…, R Gerzer, T Minuth, E Perzborn, U Pleiß, H Schröder… - Nature, 2001 - nature.com
Nitric oxide (NO) is a widespread, potent, biological mediator that has many physiological
and pathophysiological roles 1 . Research in the field of NO appears to have followed a …

The possible roles of food-derived bioactive peptides in reducing the risk of cardiovascular disease

K Erdmann, BWY Cheung, H Schröder - The Journal of nutritional …, 2008 - Elsevier
Vascular diseases such as atherosclerosis, stroke or myocardial infarction are a significant
public health problem worldwide. Attempts to prevent vascular diseases often imply …

NO‐and haem‐independent activation of soluble guanylyl cyclase: molecular basis and cardiovascular implications of a new pharmacological principle

…, M Schramm, W Schroeder, H Schröder… - British journal of …, 2002 - Wiley Online Library
Soluble guanylyl cyclase (sGC) is the only proven receptor for the ubiquitous biological
messenger nitric oxide (NO) and is intimately involved in many signal transduction pathways, …

3-D Thin film interposer based on TGV (Through Glass Vias): An alternative to Si-interposer

…, L Brusberg, N Nissen, H Schröder… - 2010 Proceedings …, 2010 - ieeexplore.ieee.org
Interposers for SiP will become more and more important for advanced electronic systems.
But through substrate vias are essential for the 3-D integration. Being a standard for laminate …

Heterogeneity in the speed of capital structure adjustment across countries and over the business cycle

…, DC Schilling, H Schröder - European Financial …, 2015 - Wiley Online Library
This study analyses the heterogeneity in the speed of capital structure adjustment. Using a
doubly‐censored Tobit estimator that accounts for mechanical mean reversion in leverage …

Capital structure decisions of globally-listed shipping companies

…, D Gounopoulos, A Merikas, H Schröder - … Research Part E …, 2013 - Elsevier
Debt capital has traditionally been the most important source of external finance in the
shipping industry. The access that shipping companies nowadays have to the capital markets …

Heme oxygenase-1 induction may explain the antioxidant profile of aspirin

…, JC Becker, T Pohle, DS Seidman, H Schröder - Biochemical and …, 2003 - Elsevier
Aspirin is known to exert antioxidant effects by as yet unidentified mechanisms. In cultured
endothelial cells derived from human umbilical vein, aspirin (30–300μM) increased heme …

The antioxidant defense protein heme oxygenase 1 is a novel target for statins in endothelial cells

…, N Wijayanti, S Immenschuh, H Schröder - Free Radical Biology …, 2004 - Elsevier
Cholesterol-independent, pleiotropic actions of hydroxymethylglutaryl coenzyme A (HMG-CoA)
reductase inhibitors (statins) exert anti-inflammatory and antioxidant action by as yet …

[HTML][HTML] Identification of residues crucially involved in the binding of the heme moiety of soluble guanylate cyclase

PM Schmidt, M Schramm, H Schröder… - Journal of Biological …, 2004 - ASBMB
Soluble guanylate cyclase (sGC), a heterodimeric hemeprotein, is the only receptor for the
biological messenger nitric oxide (NO) identified to date and is intimately involved in various …

Pharmacological profile of a novel H2S-releasing aspirin

…, R Rossi, G Rossoni, K Erdman, H Schröder… - Free Radical Biology …, 2009 - Elsevier
The pharmacological profile of a new, safe, and effective hydrogen sulfide (H 2 S)-releasing
derivative of aspirin (ACS14) is described. We report the synthesis of ACS14, and of its …